Develop Health is a technology company.
Develop Health has raised $20.0M across 2 funding rounds.
Develop Health has raised $20.0M in total across 2 funding rounds.
Develop Health is a health technology company founded in 2022 that builds an AI-powered platform for medication eligibility checking and prior authorization, automating benefit verifications, form sourcing, filling, and submission to streamline pharmacy benefit medication access.[1][2][3] It serves prescribers, ambulatory practices, hospitals, health systems, and digital health providers by solving the problem of outdated prior authorization processes that delay patient care, reducing form completion time by up to 80-83%, boosting first-time approval rates, and integrating natively into EHR workflows without requiring screen switches.[1][2][3] The platform covers over 99% of insurance plans—surpassing the industry standard of 80%—by submitting via ePA, fax, phone, or proprietary portals, while incorporating patient insurance data and clinical history for accuracy.[3]
As a young company with strong early momentum, Develop Health demonstrates product-market fit through rapid custom EHR integrations (in days, not months) and a non-dispensing pharmacy option for fully delegated workflows, earning HIPAA and SOC 2 Type 2 compliance with HITRUST planned for 2025.[1][2][3]
Develop Health was founded in 2022 by a team with deep healthcare expertise, emerging from the need to address friction in prior authorization workflows that hinder prescribers from getting patients on optimal medications quickly.[1] The idea crystallized amid growing administrative burdens in healthcare, where providers face delays from manual insurance verifications and form handling; the founders leveraged their domain knowledge to build AI-driven automation that fits seamlessly into real-world clinical operations.[1][3] Early traction came from native integrations with major EHRs and quick custom setups, proving viability in the "messy reality of healthcare," with verified customers in ambulatory practices, hospitals, and digital health by late 2025.[1][2]
Develop Health rides the AI-in-healthcare wave, targeting the prior authorization bottleneck—a multi-billion-dollar pain point exacerbated by rising specialty drug costs and payer scrutiny, where manual processes delay care by weeks.[1][3] Timing aligns with EHR modernization and value-based care shifts, amplified by post-2022 AI advancements enabling generative tools for unstructured healthcare data like PBM forms.[1][2] Market forces favoring it include regulatory pushes for ePA adoption (e.g., via CMS incentives) and payer fragmentation, which its multi-channel submission navigates effectively; it influences the ecosystem by easing admin loads for providers, accelerating medication access, and setting a bar for AI compliance in medtech.[2][3]
Develop Health is poised for scaling as AI adoption in healthcare accelerates, with next steps likely including HITRUST certification in 2025, expanded payer integrations, and pharmacy network growth to capture more delegated workflows.[3] Trends like automated claims and personalized medicine will propel it, potentially evolving from PA specialist to full revenue-cycle AI partner amid consolidation in digital health ops. Its prescriber-first momentum positions it to redefine medication access, turning a universal healthcare headache into a seamless standard.
Develop Health has raised $20.0M in total across 2 funding rounds.
Develop Health's investors include Afore Capital, Alt Capital, C2 Investment, Electric Capital, Founders Fund, Khosla Ventures, MKT1 Capital, Plaid, Ribbit Capital, Scalar Capital, Susa Ventures, Wing Venture Capital.
Develop Health has raised $20.0M across 2 funding rounds. Most recently, it raised $18.0M Series A in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2025 | $18.0M Series A | Afore Capital, Alt Capital, C2 Investment, Electric Capital, Founders Fund, Khosla Ventures, MKT1 Capital, Plaid, Ribbit Capital, Scalar Capital, Susa Ventures, Wing Venture Capital, Chase Gilbert, Derrick Li, Matt Macinnis, Parker Conrad | |
| May 1, 2023 | $2.0M Seed | Afore Capital, Alt Capital, C2 Investment, Electric Capital, Founders Fund, Khosla Ventures, MKT1 Capital, Norio Ventures, Plaid, Ribbit Capital, Scalar Capital, Susa Ventures, Chase Gilbert, Matt Macinnis, Parker Conrad |